Molecular Imaging: Page 101

PET/CT shows link between stress and fatal heart condition

By Kate Madden Yee

PET/CT has shown that increased activity in the amygdala region of the brain caused by stress can boost a person's risk of a sometimes-fatal heart condition called Takotsubo syndrome, also known as "broken heart" syndrome, according to a March 26 study in the European Heart Journal.

March 25, 2021

Dutch look for answers to fix nuclear medicine training

By Will Morton

Is there a way to stem the declining numbers of residents pursuing specialties in nuclear medicine in Europe and the U.S.? In a recent survey, Dutch researchers sought insights from residents on how to fix nuclear medicine training.

March 25, 2021

IBA reports revenue rebound in 2020

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) bounced back with growth of 10.4% in revenues in 2020 after reporting reduced revenues for the first half of the year due to challenges presented by the COVID-19 pandemic.

March 24, 2021

CMS simplifies Detectnet coding

By AuntMinnie.com staff writers

The U.S. Centers for Medicare and Medicaid Services (CMS) has simplified the coding for Detectnet, a PET diagnostic radiopharmaceutical based on copper-64 DOTATATE from RadioMedix and Curium.

March 22, 2021

Novartis touts phase III prostate cancer study results

By AuntMinnie.com staff writers

Novartis is highlighting results from a phase III study that has investigated the efficacy and safety of Lu-177 PSMA-617, a radioligand therapy for patients with prostate-specific membrane antigen-positive metastatic prostate cancer.

March 22, 2021

New radiotracer for neuroendocrine tumors appears safe

By Will Morton

A new radiopharmaceutical based on lutetium-177 being tested for the treatment of neuroendocrine tumors is safe and effective and may allow physicians to cut the radiation dose patients receive by half, according to a study published online March 19 in the Journal of Nuclear Medicine.

March 22, 2021

Novel radiotracer shows promise for prostate imaging

By Will Morton

An experimental new radiotracer is effective when used with PET/CT for detecting biochemically recurrent prostate cancer and may change patient management, according to research published online March 12 in the Journal of Nuclear Medicine.

March 21, 2021

Mich. cardiologist pays $2M to settle billing case

By AuntMinnie.com staff writers

A Michigan cardiologist and his practice paid the U.S. government $2 million to resolve allegations they violated the False Claims Act by knowingly billing federal healthcare programs for diagnostic testing that was either unnecessary or not performed.

March 18, 2021

PET/MRI study looks at head injuries and Alzheimer's disease

By Will Morton

PET/MRI showed in a recent study that a loss of cognitive function in older people due to head injuries that knocked them unconscious earlier in life was unrelated to pathology associated with Alzheimer's disease.

March 17, 2021

When will PET/MRI live up to its promise?

By Will Morton

From its early days 10 years ago to the present, PET/MRI has developed from a modality simply comparable to PET/CT to one that is changing clinical practice and becoming a potentially "killer application" in prostate cancer.

March 15, 2021

Immuno-PET shows tumor response to therapy

By AuntMinnie.com staff writers

Immuno-PET imaging illuminates a tumor's response to therapy, which could translate into better treatment for patients with cancer, according to a study published in the March issue of the Journal of Nuclear Medicine.

March 14, 2021

AI reduces FDG dose on PET imaging

By Kate Madden Yee

An artificial intelligence (AI) algorithm can process F-18 FDG PET exams acquired at two-thirds of the standard radiopharmaceutical dose and produce diagnostically effective images, according to a study published March 9 in EJNMMI Physics.

March 11, 2021

Previous Page

Page 101 of 614

Next Page